Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.10
Ask: 8.30
Change: 0.00 (0.00%)
Spread: 0.20 (2.469%)
Open: 8.10
High: 0.00
Low: 0.00
Prev. Close: 8.10
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

13 Feb 2020 16:41

RNS Number : 9733C
Oxford BioDynamics PLC
13 February 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMBLGDDBSBDGGX
Date   Source Headline
15th Mar 202311:43 amRNSAIM Rule 17 Schedule 2(g) Update
3rd Mar 20234:33 pmRNSPublication of FY22 Annual Report
23rd Feb 202310:36 amRNSPDMR Dealing
6th Feb 20237:00 amRNSOBD Prostate Screening EpiSwitch Blood Test Update
27th Jan 20232:36 pmRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSPreliminary Results and Notice of AGM
21st Dec 20227:00 amRNSNotice of FY22 Results and Investor Webinar
19th Dec 20227:00 amRNSOBD in San Francisco for JPM Healthcare conf 2023
16th Dec 20227:00 amRNSInitial assessment of EpiSwitch assay in ALS trial
14th Dec 202212:35 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSExercise period extension - existing share options
1st Dec 20222:14 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSDiscussion about EpiSwitch CiRT at Key Summit
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension
14th Nov 202211:10 amRNSDirector/PDMR Shareholding
9th Nov 20224:07 pmRNSDirector/PDMR Shareholding
8th Nov 20221:57 pmRNSHolding(s) in Company
2nd Nov 202212:37 pmRNSHolding(s) in Company
2nd Nov 202212:35 pmRNSHolding(s) in Company
2nd Nov 202212:33 pmRNSHolding(s) in Company
1st Nov 20221:20 pmRNSTotal Voting Rights
1st Nov 202212:39 pmRNSTotal Voting Rights
1st Nov 202210:57 amRNSHolding(s) in Company
31st Oct 202211:05 amRNSHolding(s) in Company
31st Oct 202211:04 amRNSHolding(s) in Company
31st Oct 202211:02 amRNSHolding(s) in Company
31st Oct 202210:58 amRNSHolding(s) in Company
31st Oct 202210:57 amRNSHolding(s) in Company
31st Oct 202210:56 amRNSHolding(s) in Company
28th Oct 20222:36 pmRNSHolding(s) in Company
27th Oct 202212:09 pmRNSResult of General Meeting, Director/PDMR Dealings
25th Oct 20222:30 pmRNSResult of Open Offer
7th Oct 202212:00 pmRNSProposed Placing and Open Offer
3rd Oct 20227:00 amRNSUS Reimbursement Code for CiRT now available
15th Sep 20227:00 amRNSESMO data highlights unique benefit of EpiSwitch
6th Sep 20227:00 amRNSCiRT highlighted at ESMO 2022 presentation
5th Jul 20227:00 amRNSUS reimbursement code for EpiSwitch® CiRT
1st Jul 20224:13 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSHalf-year Report
21st Jun 20227:00 amRNSEpiSwitch® CiRT now available in the UK
17th Jun 20227:00 amRNSNotice of Interim Results Webinar
15th Jun 20227:00 amRNSNotice of Results
14th Jun 20227:00 amRNSOBD EpiSwitch® CiRT well received at ASCO 2022
20th May 20223:50 pmRNSDirector/PDMR Shareholding
20th May 20227:00 amRNSPDMR Dealing / Grant of Share Options
13th May 20223:57 pmRNSPDMR Dealing / Grant of Share Options
5th May 20227:00 amRNSOBD to present CiRT clinical utility data at ASCO
28th Apr 202210:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.